AIM ImmunoTech Inc. (AIM): Wutah pendapatan kuartal marang kuartal

Logo korporat perusahaan AIM ImmunoTech (AIM)

AIM ImmunoTech is diversifying its developments in oncology and fatigue therapy, allocating costs between the US and European markets. The quarterly revenue growth rate visualizes this strategy, where the current status equals -15.40. However, delays in the rollout of Ampligen are eroding margins, and ultimate success in the patent-protected niche depends solely on FDA verdicts regarding clinical phases.

AIM ImmunoTech, Inc. (AIM) - Tambahing pendapatan triwulanan saka 04.07.2022 nganti 20.11.2026

AIM (aimimmuno.com): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:
Analisis wiwitan perusahaan:AIM ImmunoTech, Inc. - AIM
Produk seri AIM ImmunoTech

For AIM ImmunoTech, stable demand for the unique drug Ampligen makes monitoring operational sales critical for assessing the business's rent-seeking potential. This metric calculates the percentage change in revenue from the current quarter to the previous one, allowing investors to filter out one-time anomalies and identify real demand trends. By analyzing the QoQ revenue growth rate, one can confirm the stability of the company's market position and the absence of hidden liquidity risks.

Pesaing AIM ImmunoTech (AIM)

argenx BVBA - Wutah pendapatan triwulanan|BNTX: Wutah pendapatan kuartal marang kuartal|ABVX: Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal ADMA|Wutah pendapatan kuartal marang kuartal protagonist-inc.com|Wutah dodolan triwulanan Immunovant, Inc. (IMVT)|Wutah pendapatan triwulanan KNSA|GRFS: Dinamika pendapatan kuartal marang kuartal|Adaptive Biotechnologies - Wutah dodolan triwulanan|CLDX: Wutah dodolan kuartal marang kuartal|Aurinia Corp - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioCryst Corp|VERA: Wutah pendapatan triwulanan|dianthustx.com (DNTH) - Wutah pendapatan triwulanan|PHVS (Pharvaris NV) - Wutah pendapatan triwulanan|ABCL: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PHAR (Pharming Corp)|nektar.com (NKTR) - Tingkat wutah pendapatan sajrone kuartal|UPB - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ZBIO (Zenas Biopharma)|IMNM: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Gossamer Bio, Inc. (GOSS)|Wutah pendapatan kuartal marang kuartal KalVista Pharmaceuticals|Septerna Inc (SEPN) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan PVLA|SVRA (Savara) - Tambahing pendapatan triwulanan|Rigel Pharma - Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal AnaptysBio Corp (ANAB)|ATXS: Wutah dodolan triwulanan|Tambahing pendapatan triwulanan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Wutah pendapatan kuartal marang kuartal|Aerovate Therapeutics Inc (JBIO) - Wutah pendapatan triwulanan|ACRS (Aclaris Therapeutics, Inc) - Wutah pendapatan triwulanan|Kyverna (KYTX) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan TLSA|Wutah dodolan triwulanan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Wutah dodolan triwulanan|THTX: Wutah dodolan kuartal marang kuartal|AVTX - Wutah pendapatan kuartal marang kuartal|ELDN: Wutah pendapatan kuartal marang kuartal|Agenus Inc. (AGEN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Climb Bio Inc|ZURA (Zura Bio Ltd) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan aTyr Pharma Inc|Wutah pendapatan triwulanan ADAG|Tingkat wutah dodolan sajrone kuartal ImageneBio|Wutah pendapatan triwulanan STTK (Shattuck Labs Inc)|Wutah pendapatan triwulanan Equillium, Inc. EQ|CNTB - Wutah pendapatan kuartal marang kuartal|Immunic Therapeutics (IMUX) - Wutah dodolan triwulanan|ATRA: Wutah pendapatan triwulanan|InflaRx GmbH (IFRX) - Wutah pendapatan triwulanan|XFOR (x4pharma.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Adicet Bio|Wutah pendapatan kuartal marang kuartal Celularity Inc (CELU)|Wutah dodolan triwulanan INmune Bio Corp INMB|Wutah pendapatan kuartal marang kuartal Barinthus Biotherapeutics plc BRNS|KZR - Wutah dodolan triwulanan|sabbiotherapeutics.com - Wutah pendapatan triwulanan|akaritx.com (AKTX) - Wutah dodolan triwulanan|ENLV: Wutah pendapatan triwulanan|QTTB (Q32 Bio Inc) - Wutah pendapatan kuartal marang kuartal|GOVX (geovax.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Edesa Biotech Corp|Wutah pendapatan triwulanan IBIO|Wutah dodolan triwulanan Carisma Tx CARM|Wutah pendapatan kuartal marang kuartal XTL Biopharmaceuticals Ltd XTLB|Wutah pendapatan triwulanan Bolt Biotherapeutics BOLT|HCW Biologics - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal aptevotherapeutics.com|Aditxt Corp (ADTX) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal GRI|Wutah dodolan triwulanan XRTX|Tingkat wutah pendapatan sajrone kuartal Vyome Holdings Inc. HIND|Wutah pendapatan triwulanan REVB|Tingkat wutah dodolan sajrone kuartal Indaptus Corp|BiondVax Pharmaceuticals - Wutah dodolan triwulanan|CalciMedica Corp (CALI) - Tingkat wutah pendapatan sajrone kuartal|Affimed - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal allakos.com ALLK|HOOKIPA Pharma (HOOK) - Wutah pendapatan kuartal marang kuartal|IGMS (IGM Biosciences Inc.) - Wutah pendapatan kuartal marang kuartal|ITOS (iTeos Therapeutics) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal OCEA (Ocean Biomedical)|Wutah pendapatan kuartal marang kuartal TC Biopharm (TCBP)|THRD (Third Harmonic Bio Inc.) - Tambahing pendapatan triwulanan